The potential biomarkers of drug addiction: proteomic and metabolomics challenges

References

• Adkins DE, McClay JL, Vunck SA, et al. (2013). Behavioral metabolomics analysis identifies novel neurochemical signatures in methamphetamine sensitization. Genes Brain Behav 12:780–91.
   PubMed Web of Science ®Google Scholar
• Blanchet L, Smolinska A, Attali A, et al. (2011). Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics 12:254.
   PubMed Web of Science ®Google Scholar
• Bu Q, Lv L, Yan G, et al. (2013). NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats. Neurotoxicology 36:17–23.
   PubMed Web of Science ®Google Scholar
• Bu Q, Yang Y, Yan G, et al. (2012). Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention. J Proteomics 75:1330–42.
   PubMed Web of Science ®Google Scholar
• Craft GE, Chen A, Nairn AC. (2013). Recent advances in quantitative neuroproteomics. Methods 61:186–218.
   PubMed Web of Science ®Google Scholar
• Deng Y, Bu Q, Hu Z, et al. (2012). 1H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal intervention. J Neurosci Res 90:2154–62.
   PubMed Web of Science ®Google Scholar
• Diaz-Flores Estevez JF, Diaz-Flores Estevez F, Hernandez Calzadilla C, et al. (2004). Application of linear discriminant analysis to the biochemical and haematological differentiation of opiate addicts from healthy subjects: a case-control study. Eur J Clin Nutr 58:449–55.
   PubMed Web of Science ®Google Scholar
• Diaz SO, Pinto J, Graça G, et al. (2011). Metabolic biomarkers of prenatal disorders: An exploratory NMR metabonomics study of second trimester maternal urine and blood plasma. J Proteome Res 10:3732–42.
   PubMed Web of Science ®Google Scholar
• Dominy SS, Brown JN, Ryder MI, et al. (2014). Proteomic analysis of saliva in HIV-positive heroin addicts reveals proteins correlated with cognition. PLoS One 9:e89366.
   Google Scholar
• Everitt BJ, Robbins TW. (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8:1481–9.
   PubMed Web of Science ®Google Scholar
• Ezquerra L, Alguacil LF, Nguyen T, et al. (2008). Different pattern of pleiotrophin and midkine expression in neuropathic pain: correlation between changes in pleiotrophin gene expression and rat strain differences in neuropathic pain. Growth Factors 26:44–8.
   PubMed Web of Science ®Google Scholar
• Filipeanu CM, Guidry JJ, Leonard ST, Winsauer PJ. (2011). Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use. J Neurochem 118:1101–12.
   PubMed Web of Science ®Google Scholar
• Gika HG, Wilson ID. (2014). Global metabolic profiling for the study of alcohol-related disorders. Bioanalysis 6:59–77.
   PubMed Web of Science ®Google Scholar
• Gorini G, Harris RA, Mayfield RD. (2014). Proteomic approaches and identification of novel therapeutic targets for alcoholism. Neuropsychopharmacology 39:104–30.
   PubMed Web of Science ®Google Scholar
• Gramage E, Herradon G, Martin YB, et al. (2013). Differential phosphoproteome of the striatum from pleiotrophin knockout and midkine knockout mice treated with amphetamine: correlations with amphetamine-induced neurotoxicity. Toxicology 306:147–56.
   PubMed Web of Science ®Google Scholar
• Gruber MP, Coldren CD, Woolum MD, et al. (2006). Human lung project: evaluating variance of gene expression in the human lung. Am J Respir Cell Mol Biol 35:65–71.
   PubMed Web of Science ®Google Scholar
• Hu Z, Deng Y, Hu C, et al. (2012). ¹H NMR-based metabonomic analysis of brain in rats of morphine dependence and withdrawal intervention. Behav Brain Res 231:11–19.
   PubMed Web of Science ®Google Scholar
• Iwazaki T, McGregor IS, Matsumoto I. (2008). Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. Neurosci Lett 435:113–19.
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R, Krishnan KRR. (2009). Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34:173–86.
   PubMed Web of Science ®Google Scholar
• Kendler KS, Myers J, Prescott CA. (2007). Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry 64:1313–20.
   PubMed Web of Science ®Google Scholar
• Krapfenbauer K, Engidawork E, Cairns N, et al. (2003). Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res 967:152–60.
   PubMed Web of Science ®Google Scholar
• Krastanov A. (2010). Metabolomics – the state of art. Biotechnol Biotech Eq 24:1537–43.
   Web of Science ®Google Scholar
• Le Greves P. (2005). Pleiotrophin gene transcription in the rat nucleus accumbens is stimulated by an acute dose of amphetamine. Brain Res Bull 65:529–32.
   PubMed Web of Science ®Google Scholar
• Li Y, Yan GY, Zhou JQ, et al. (2012). ¹H NMR-based metabonomics in brain nucleus accumbens and striatum following repeated cocaine treatment in rats. Neuroscience 218:196–205.
   PubMed Web of Science ®Google Scholar
• Lichti CF, Fan X, English RD, et al. (2014). Environmental enrichment alters protein expression as well as the proteomic response to cocaine in rat nucleus accumbens. Front Behav Neurosci 8:246.
   PubMed Web of Science ®Google Scholar
• Lin X, Wang Q, Cheng Y, et al. (2011). Changes of protein expression profiles in the amygdala during the process of morphine-induced conditioned place preference in rats. Behav Brain Res 221:197–206.
   PubMed Web of Science ®Google Scholar
• Ling YS, Liang HJ, Chung MH, et al. (2014). NMR- and MS-based metabolomics: various organ responses following naphthalene intervention. Mol Biosyst 10:1918–31.
   PubMed Web of Science ®Google Scholar
• Lull ME, Freeman WM, VanGuilder HD, Vrana KE. (2010). The use of neuroproteomics in drug abuse research. Drug Alcohol Depend 107:11–22.
   PubMed Web of Science ®Google Scholar
• Mailleux P, Preud'homme X, Albala N, et al. (1994). delta-9-Tetrahydrocannabinol regulates gene expression of the growth factor pleiotrophin in the forebrain. Neurosci Lett 175:25–7.
   PubMed Web of Science ®Google Scholar
• Makris N, Gasic GP, Seidman LJ, et al. (2004). Decreased absolute amygdala volume in cocaine addicts. Neuron 44:729–40.
   PubMed Web of Science ®Google Scholar
• Mannelli P, Patkar A, Rozen S, et al. (2009). Opioid use affects antioxidant activity and purine metabolism: preliminary results. Hum Psychopharmacol 24:666–75.
   PubMed Web of Science ®Google Scholar
• Martins-de-Souza D, Gattaz WF, Schmitt A, et al. (2009). Proteome analysis of schizophrenia patients Wernicke’s area reveals an energy metabolism dysregulation. BMC Psychiatry 9:17.
   PubMed Web of Science ®Google Scholar
• McClay JL, Adkins DE, Vunck SA, et al. (2013). Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure. Metabolomics 9:392–402.
   PubMed Web of Science ®Google Scholar
• Meng J, Zhang X, Wu H, et al. (2012). Morphine-induced conditioned place preference in mice: metabolomic profiling of brain tissue to find “molecular switch” of drug abuse by gas chromatography/mass spectrometry. Anal Chim Acta 710:125–30.
   PubMed Web of Science ®Google Scholar
• Naylor S. (2003). Biomarkers: current perspectives and future prospects. Expert Rev Mol Diagn 3:525–9.
   PubMed Web of Science ®Google Scholar
• Nestler EJ. (2004). Molecular mechanisms of drug addiction. Neuropharmacology 47:24–32.
   PubMed Web of Science ®Google Scholar
• Nordstrom A, Lewensohn R. (2010). Metabolomics: moving to the clinic. J Neuroimmune Pharmacol 5:4–17.
   PubMed Web of Science ®Google Scholar
• Patkar AA, Rozen S, Mannelli P, et al. (2009). Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology 206:479–89.
   PubMed Web of Science ®Google Scholar
• Potenza MN, Sofuoglu M, Carroll KM, Rounsaville BJ. (2011). Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 69:695–712.
   PubMed Web of Science ®Google Scholar
• Pottiez G, Jagadish T, Yu F, et al. (2012). Plasma proteomic profiling in HIV-1 infected methamphetamine abusers. PLoS One 7:e31031.
   Google Scholar
• Power JH, Asad S, Chataway TK, et al. (2008). Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology. Acta Neuropathol 115:611–22.
   PubMed Web of Science ®Google Scholar
• Robison AJ, Nestler EJ. (2011). Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623–37.
   PubMed Web of Science ®Google Scholar
• Shi WL, Zhao X, Liu ZM, et al. (2012). Serum proteomics of methamphetamine addicts and up-regulation of complement factor H related to methamphetamine addiction. Neurosci Lett 525:23–8.
   PubMed Web of Science ®Google Scholar
• Shima N, Miyawaki I, Bando K, et al. (2011). Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat. Toxicology 287:29–37.
   PubMed Web of Science ®Google Scholar
• Stockton SD Jr., Devi LA. (2014). An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure. Neuropsychopharmacology 39:88–103.
   PubMed Web of Science ®Google Scholar
• Taurines R, Dudley E, Grassl J, et al. (2011). Proteomic research in psychiatry. J Psychopharmacol 25:151–96.
   PubMed Web of Science ®Google Scholar
• Vicente-Rodriguez M, Gramage E, Herradon G, Perez-Garcia C. (2013). Phosphoproteomic analysis of the striatum from pleiotrophin knockout and midkine knockout mice treated with cocaine reveals regulation of oxidative stress-related proteins potentially underlying cocaine-induced neurotoxicity and neurodegeneration. Toxicology 314:166–73.
   PubMed Web of Science ®Google Scholar
• Wang-Sattler R, Yu Y, Mittelstrass K, et al. (2008). Metabolic profiling reveals distinct variations linked to nicotine consumption in humans-first results from the KORA study. PLoS One 3:e3863.
   Google Scholar
• Wang J, Yuan W, Li MD. (2011). Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses. Mol Neurobiol 44:269–86.
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy R. (2011). Oxidative stress in schizophrenia: pathogenetic and therapeutic implications. Antioxid Redox Signal 15:1999–2002.
   PubMed Web of Science ®Google Scholar
• Zaitsu K, Miyawaki I, Bando K, et al. (2014). Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference. Anal Bioanal Chem 406:1339–54.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Lin RC. (2014). UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics. Chem Biol Interact 215:7–16.
   PubMed Web of Science ®Google Scholar
• Zheng T, Liu L, Aa J, et al. (2013). Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse. Drug Alcohol Depend 127:177–86.
   PubMed Web of Science ®Google Scholar
• Zheng T, Liu L, Shi J, et al. (2014). The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse. Mol Biosyst 10:1968–77.
   PubMed Web of Science ®Google Scholar
• Zill P, Vielsmeier V, Büttner A, et al. (2011). Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior. Eur Arch Psychiatry Clin Neurosci 261:121–31.
   PubMed Web of Science ®Google Scholar